- (2023): Nakao Y+, Pharmaceuticals (Basel) 16(10), 1500 (FDA Adverse Event Reporting System data)
Adverse reactions attributed to entire drug class 'Contrast agent'
Please login to view adverse reactions.
Kounis syndrome / allergic angina syndrome / allergic myocardial infarction
- (2021): Wang C+, Am J Emerg Med 52, 203-207 (26 cases)
Encephalopathy (includes hepatic encephalopathy)
- (2025): Mariajoseph FP+, Neuroradiology Mar, Online ahead of print
- (2024): Hill KA+, BMJ Case Rep 17(3), e259525 (1 case / female)
- (2024): Kollmar R+, Dtsch Arztebl Int 121(1), 24 (1 case / female)
- (2024): Mitsui N+, J Neuroendovasc Ther 18(11), 287-2926%
- (2024): Mariajoseph FP+, Acta Neurol Belg Feb, Online ahead of print [REVIEW]
- (2024): Mariajoseph FP+, Acta Neurol Belg Sep, Online ahead of print3%
- (2023): Mariajoseph FP+, J Clin Neurosci Aug, 8-12, Online ahead of print [REVIEW]
Creatinine increased (see serum creatinine increased)
- (2020): Chyrchel M+, J Clin Med 9(6), E1812
- (2019): Rainey SC+, J Pediatr Pharmacol Ther 24(6), 534 (3 cases)
(with propofol)
- (2024): Mitsui N+, J Neuroendovasc Ther 18(11), 287-29236% (contrast extravasation (contrast leakage))
- (2025): Söner S+, BMC Cardiovasc Disord 25 (1), 31
- (2025): Zhao Y+, BMC Cardiovasc Disord 25(1), 135
- (2024): Fan G+, Eur J Clin Pharmacol Dec, Online ahead of print [REVIEW]
- (2024): Ömür SE+, Turk Kardiyol Dern Ars 52(8), 543-552
- (2024): Özbeyaz NB+, Rev Assoc Med Bras (1992) Aug (e-Collection)
- (2024): Usta A+, Reprod Biol Endocrinol 22(1), 15612% (2% severe)
- (2024): Zhai Y+, Front Cardiovasc Med Aug (e-Collection) 23%
- (2022): Güzel T+, Rev Assoc Med Bras (1992) Aug, Online ahead of print
- (2022): Watanabe M+, Circ J Apr, Online ahead of print (association with use of high-dose pitavastatin)
- (2022): Wu X+, Medicine (Baltimore) 101(52), e32432 [REVIEW]
- (2021): Huyut MA, Arq Bras Cardiol, Online ahead of print (15 cases)
- (2021): Khalfallah M+, Glob Heart 16(1), 5711%
- (2021): Raffort J+, Curr Vasc Pharmacol Jul, Online ahead of print [REVIEW]
- (2020): Chyrchel M+, J Clin Med 9(6), E18122-8%
- (2019): Khalfallah M+, Glob Heart 14(3), 2959–10% (in patients with pre-existing heart disease)
- (2013): Mohammed NM+, Heart Views 14(3), 106-16 [REVIEW]
Nephrotoxicity / kidney injury / acute kidney injury (AKI) / drug-induced kidney injury
- (2025): Zhang G+, J Inflamm Res 18, 5149-5159
- (2024): Choi B+, Invest Radiol Dec, Online ahead of print
- (2024): Fu C+, PeerJ Jun (e-Collection) (association)
- (2024): Jong CB+, PLoS One 19(10), e0312618
- (2024): Zhang Y+, Curr Vasc Pharmacol Nov, Online ahead of print [REVIEW]
- (2022): Rey A+, Fundam Clin Pharmacol Jan, Online ahead of print
- (2021): Yan G+, Int J Gen Med 14, 3087-3097
- (2014): Prasad V+, Radiology 273(3), 853 [REVIEW]
- (2021): Wang C+, Am J Emerg Med 52, 203-207 (2 cases)
